Day: June 16, 2021

Dr. Slavin Brings Deep Clinical, Academic and Industry Experience to New Role SALT LAKE CITY, June 16, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has named Thomas P. Slavin Jr. (T.J.), M.D., FACMG, DABMD, chief medical officer of the company. He will report directly to Nicole Lambert, president of Myriad Genetic Laboratories. In his new role, Dr. Slavin will apply deep clinical and scientific expertise, combined with proven leadership and experience in precision medicine, to further elevate Myriad’s portfolio of genetic tests spanning oncology, women’s health and mental health. Previously, Dr. Slavin served as senior vice president of Medical Affairs for Oncology at Myriad Genetics. “We are fortunate to have a widely recognized expert...

SEATTLE, June 16, 2021 (GLOBE NEWSWIRE) — A Place for Rover, Inc. (“Rover” or the “Company”), the world’s largest online marketplace for pet care, today announced that Co-Founder & CEO Aaron Easterly and CFO Tracy Knox will host a fireside chat at the Wells Fargo ‘Bricks to Clicks’ Digital Conference on June 23, 2021 at 12:40 p.m. ET (9:40 a.m. PT). In addition, management will host virtual one-on-one and small group meetings with institutional investors during the conference. The live presentation can be accessed here. On February 10, 2021, Rover entered into a definitive business combination agreement with Nebula Caravel Acquisition Corp. (Nasdaq: NEBC) (“Caravel”). Caravel is a publicly traded special purpose acquisition company sponsored by True Wind Capital. The transaction values Rover at an enterprise value of approximately...

SOLANA BEACH, Calif., June 16, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its version 2.0 software at Mazowiecki Szpital Bródnowski in Warsaw, Poland. “We appreciated the patience and commitment of the on-site ClearPoint team throughout the installation process,” stated Professor Mirosław Ząbek, Head of the Neurosurgery Clinic at Mazowiecki Szpital Bródnowski. “Our entire team is looking forward to begin performing DBS, biopsy and clinical trial cases with the ClearPoint Neuro Navigation System.” “Dr. Ząbek and his team have been involved in cutting-edge drug delivery protocols for many years,” commented Matt Rabon, Clinical and Business Development Manager, EMEA. “Poland is one of the...

MCLEAN, Va., June 16, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) has priced a new offering of Structured Pass-Through Certificates (K Certificates), which includes a class of floating rate bonds indexed to the Secured Overnight Financing Rate (SOFR). The approximately $886 million in K Certificates (K-F114 Certificates) are expected to settle on or about June 24, 2021. The K-F114 Certificates are backed by floating-rate multifamily mortgages with 10-year terms, which are SOFR-based. K-F114 PricingClass Principal/Notional Amount (mm) Weighted Average Life (Years) Discount Margin Coupon Dollar PriceAS $886.487 9.54 22 30-day SOFR avg + 22 100.000XS Non-OfferedDetailsCo-Lead Managers and Joint Bookrunners: Goldman Sachs & Co. LLC and Barclays Capital Inc. Co-Managers: Amherst Pierpont Securities LLC, Brownstone...

Not for distribution in the United States or through US newswire services. CALGARY, Alberta, June 16, 2021 (GLOBE NEWSWIRE) — Huntington Exploration Inc. (TSX.V–HEI) (“Huntington” or the “Company”) is pleased to announce that it has closed its private placement with Canaccord Genuity Corp. and Sprott Capital Partners, as co-lead agents, on behalf of a syndicate of agents including Cormark Securities Inc. (collectively, the “Agents”) for gross proceeds of C$6,000,000 comprised of units (“HD Units”) sold at a price of C$0.28 per HD Unit. The Company also announces the completion of the previously announced contemporaneous non-brokered private placement of flow-through units (“FT Units”) sold at a price of C$0.35 per FT Unit for aggregate gross proceeds of C$2,500,000, for total gross proceeds of C$8,500,000 (the “Offering”). Each...

HOLLYWOOD, FL, June 16, 2021 (GLOBE NEWSWIRE) — Healthier Choices Management Corp. (OTC Pink: HCMC) (“HCMC or the “Company”) announced that Philip Morris Products S.A. (“Philip Morris”) filed a petition with the Patent Trial and Appeal Board (the “PTAB”) of the U.S. Patent and Trademark Office seeking to institute inter partes review (“IPR”) proceedings to invalidate Healthier Choices Management Corp.’s (the “Company”) U.S. Patent No. 10,561,170 (the “Patent”). If Philip Morris’ IPR petition is accepted by the PTAB, the Company will have three months to optionally file a preliminary response. Within three months of the Company’s preliminary response or six months from acceptance of Philip Morris’ IPR petition, the PTAB will decide whether to institute or deny the IPR proceedings. If the PTAB institutes IPR proceedings, then within...

According to management accounts for April and May, which are now available, along with a forecast for June, it is estimated that EBITDA from the operation in second quarter 2021 will be considerably higher than results for the same quarter last year and better than management expectations. However, the settlement made with the Icelandic Competition Authority, announced earlier today, will have a negative impact on the results. The operation so far this quarter has been generally good despite challenging market conditions. Volume in the liner services has been strong, the utilization in the container liner system has been high and the performance in forwarding services has been good. Furthermore, revenue management program already initiated and streamlining measures from last year are strengthening the performance. The estimated adjusted...